March 7, 2022, Chengdu, China -Keymed Biosciences Inc. (HKEX:02162) is pleased to announce that the shares of the Company have been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect with effect from March 7, 2022, pursuant to the announcement issued by the Shenzhen Stock Exchange. This means that domestic investors who meet the relevant eligibility criteria can trade the Company's shares directly through the Hong Kong Stock Connect. Previously, the Company was included in eight Hang Seng indices, including the Hang Seng Composite Index (HSCI) and the Hang Seng Healthcare Index, and the change has also taken effect today.
Company Profile Management Team Milestones Corporate Culture
R&D Center Pipeline Manufacturing Park Cooperation Expanded Access Policy
Corporate Governance Information Disclosure Financial Reports Stock Information IR Calendar Investor Presentations Email Alerts
Latest News Media
Culture & Benefits
Contact Information Consultation Legal Statement Privacy